PubHawk
N Engl J Med August 2025 PMID 40470996

Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes.

Rajiv Agarwal, Jennifer B Green, Hiddo J L Heerspink, Johannes F E Mann, Janet B McGill, Amy K Mottl, Julio Rosenstock, Peter Rossing, Muthiah Vaduganathan, Meike Brinker, Robert Edfors, Na Li, Markus F Scheerer, Charlie Scott, Masaomi Nangaku

Full text PDF Download social card

Mentions

307
Peak: 113 in Aug 2025
across 5 sources since Jun 2025

Extended reach

2,565,224
potential audience

Total likes

555

Video views

659

Mentions per month

Jun 2025 – Oct 2025

Where it's discussed

  • X / Twitter204 posts
  • News86 articles
  • Bluesky10 posts
  • Blogs5 articles
  • YouTube2 videos

AI synopsis

What people are saying

Many discussions highlighted the summary of results such as the combination therapy leading to a 30% greater reduction in urinary albumin-to-creatinine ratios. Terms like 'promising step' and 'excellent option' underscore the positive tone, and phrases like 'without unexpected adverse effects' establish a reassuring context about safety. The overall enthusiasm and supportive language reflect the importance of these findings in the medical community.

AgreementStrong agreement

The discussions reveal strong consensus in favor of the combined therapy, as many users express clear support for its effectiveness.

InterestHigh interest

There is a high level of curiosity around the research findings, with numerous users actively discussing and sharing additional information.

EngagementHigh engagement

Participants are deeply engaged, providing detailed analyses and references to specific results from the study, indicating thoughtful dialogue.

ImpactHigh impact

Users perceive the study as having significant implications for treatment in chronic kidney disease and type 2 diabetes, suggesting transformative potential.

Abstract in brief

  • The study investigates the effects of combining finerenone, a new type of medication for kidney disease, with empagliflozin, a diabetes treatment, in patients with chronic kidney disease and type 2 diabetes.
  • The participants were randomly assigned to three groups: one taking finerenone, one taking empagliflozin, and one taking both, with their urine albumin-to-creatinine ratios measured over 180 days.
  • Results showed that the combination therapy reduced urinary albumin-to-creatinine ratios significantly more than either medication alone, and there were no unexpected adverse effects reported.
Read the full abstract

Top posts

Most liked on X and Bluesky
NEJM
@NEJM · X

Original Article: Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes (CONFIDENCE trial) https://t.co/AqeFwQNqpn Editorial: Combination Therapy for Chronic Kidney Disease and Type 2 Diabetes — A Promising Prelude https://t.co/83I3getbLw #Endocrinology https://t.co/gUuxxgSLiH

Aug 8, 2025 · 144 likes · 54 shares · 935,950 followers View post →
NEJM
@NEJM · X

New in the August 7, 2025, issue of NEJM: Finerenone with Empagliflozin in CKD and Diabetes (CONFIDENCE trial) https://t.co/AqeFwQNqpn Ciprofloxacin Monotherapy for Bubonic Plague (IMASOY trial) https://t.co/N42b8KPRxE Vepdegestrant in Advanced Breast Cancer (VERITAC-2 https://t.co/1A7jzMFxN6

Aug 7, 2025 · 100 likes · 25 shares · 935,950 followers View post →
Jasmine Sethi
@JasmineNephro · X

Jun 6, 2025 · 93 likes · 29 shares · 25,811 followers View post →
Namesh kamat
@namesh217 · X

Jul 7, 2025 · 39 likes · 12 shares · 245 followers View post →
Ahmed Bennis MD
@drbennisahmed · X

Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes initial therapy with finerenone plus empagliflozin led to a greater reduction in the urinary albumin-to-creatinine ratio than either treatment alone https://t.co/wpQWmMUCV5 https://t.co/vpmimxGRzq

Jun 20, 2025 · 22 likes · 8 shares · 2,764 followers View post →
Ahmed Bennis MD
@drbennisahmed · X

Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes At day 180, the reduction in the urinary albumin-to-creatinine ratio with combination therapy was 29% greater than that with finerenone alone and 32% greater than that with empagliflozin alone Among https://t.co/wUI6aZNp09

Jun 30, 2025 · 19 likes · 7 shares · 2,764 followers View post →

All mentions

xD ⁷
@Dm1AMI · X

RT @Nephro_Ivan: La unión hace la fuerza

Oct 11, 2025 · 21 shares · 74 followers View post →
RedGDPS
@redgdps.bsky.social · Bluesky

Bibliografía en @PubMedOnline Agarwal R, et al.; CONFIDENCE Investigators. Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes. N Engl J Med. 2025 Aug 7;393(6):533-543. doi: 10.1056/NEJMoa2410659. pubmed.ncbi.nlm.nih.gov/40470996/

Oct 2, 2025 · 1 share View post →
RedGDPS
@redgdps.bsky.social · Bluesky

Full text links Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes Rajiv Agarwal el al. www.nejm.org/doi/pdf/10.1...

Oct 2, 2025 View post →
redGDPS Diabetes
@redGDPS · X

Full text links Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes Rajiv Agarwal el al. https://t.co/Cd1UqYvfUT

Oct 2, 2025 · 15,535 followers View post →
redGDPS Diabetes
@redGDPS · X

Bibliografía en @PubMedOnline Agarwal R, et al.; CONFIDENCE Investigators. Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes. N Engl J Med. 2025 Aug 7;393(6):533-543. doi: 10.1056/NEJMoa2410659. https://t.co/n5vWCts3li https://t.co/c0HxZpWBaQ

Oct 2, 2025 · 15,534 followers View post →
Dr.Ahmed Saleh Alhemkani
@alhmyqany_d · X

RT @namesh217:

Sep 16, 2025 · 12 shares · 78 followers View post →
Filemón Esteban López Pérez
@ecbky · X

Finerenona con empagliflozina en la enfermedad renal crónica y la diabetes tipo 2 | New England Journal of Medicine https://t.co/HXmtP6AH0x

Sep 2, 2025 · 215 followers View post →
Bhargav Reddy
@Bhargav86747467 · X

CONFIDENCE trial: In CKD + type 2 diabetes patients, combining finerenone + empagliflozin cut urinary albumin-to-creatinine ratio more than either alone — a promising step in kidney protection.

Aug 17, 2025 · 36 followers View post →
STITCHES Medicine - the Best of Medical Research
@medicine.stitches.today · Bluesky

Finerenone plus empagliflozin cut albuminuria ~30% more than either drug alone in CKD with T2D, without excess adverse events. by Agarwal R, Green JB (...) Nangaku M et 12 al. in N Engl J Med #MedSky

Aug 16, 2025 View post →
STITCHES Medicine - the Best of Medical Research
@STITCHESMed · X

Finerenone plus empagliflozin cut albuminuria ~30% more than either drug alone in CKD with T2D, without excess adverse events. by Agarwal R, Green JB (...) Nangaku M et 12 al. in N Engl J Med https://t.co/OOxNHaR3ES #MedX #MedResearch

Aug 16, 2025 · 87 followers View post →
Celeste Monsun
@Ohmyceleste · X

RT @crz_garrit: Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes | New England Journal of Medicine https://t.co/…

Aug 16, 2025 · 4 shares · 348 followers View post →
ignacio villanueva bendek
@ignacio_bendek · X

RT @crz_garrit: Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes | New England Journal of Medicine https://t.co/…

Aug 14, 2025 · 4 shares · 37 followers View post →
George Kolostoumpis
@gkolost · X

RT @NEJM: Original Article: Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes (CONFIDENCE trial) https://t.co/Aqe…

Aug 12, 2025 · 54 shares · 2,085 followers View post →
Dr.NefroBoy
@iAlanagc · X

RT @DiegoGonzlezGu1:

Aug 12, 2025 · 1 share · 71 followers View post →
医療法人社団ゆみの
@yumino_medical · X

【DrゆみのWeekly Journal Scan】 ＊DKD患者におけるMRA＋SGLT2阻害薬の早期併用効果 from NEJM＊ https://t.co/Q5q7pNY7F2

Aug 12, 2025 · 6 likes · 1,242 followers View post →
Andres Felipe Florez
@Andresffmed · X

RT @NEJM: Original Article: Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes (CONFIDENCE trial) https://t.co/Aqe…

Aug 11, 2025 · 54 shares · 158 followers View post →
Dr. Fernando
@rotavirus1980 · X

Finerenona con empagliflozina en la enfermedad renal crónica y la diabetes tipo 2 | Revista de Medicina de Nueva Inglaterra https://t.co/lrXK1QdEhb

Aug 11, 2025 · 187 followers View post →
MC
@atram_8 · X

RT @NEJM: Original Article: Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes (CONFIDENCE trial) https://t.co/Aqe…

Aug 11, 2025 · 54 shares · 75 followers View post →
Edgard Pais
@Edgard_2015 · X

Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes | New England Journal of Medicine https://t.co/FZs5XFGHfr

Aug 10, 2025 · 213 followers View post →
Iván Darío Bravo Tobar. M.D. | M.Sc. | Ph.D.
@idbravotobar.bsky.social · Bluesky

Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes | New England Journal of Medicine www.nejm.org/doi/full/10....

Aug 10, 2025 · 4 likes View post →
JECCmed95
@JECCmed95 · X

RT @SEMERGENap: Estudio CONFIDENCE (NEJM, 2025): en DM2 y ERC, la combinación finerenona + empagliflozina logró reducir un 29-32% la relaci…

Aug 10, 2025 · 3 shares · 144 followers View post →
Sharona Azriel
@SharonaAzriel · X

RT @NEJM: Original Article: Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes (CONFIDENCE trial) https://t.co/Aqe…

Aug 10, 2025 · 54 shares · 1,407 followers View post →
Maribel Montoro
@MaribelMontoroO · X

RT @SEMERGENap: Estudio CONFIDENCE (NEJM, 2025): en DM2 y ERC, la combinación finerenona + empagliflozina logró reducir un 29-32% la relaci…

Aug 10, 2025 · 3 shares · 316 followers View post →
Erick F. Sandoval
@ericknando23 · X

Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes | New England Journal of Medicine https://t.co/pqIyWj9dLp

Aug 10, 2025 · 133 followers View post →
Raphael Biedermann MD
@EndoCases · X

Interesting results, underscoring the recommended approach of the treatment of CKD in Diabetes patients. Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes | New England Journal of Medicine https://t.co/P2B3icm5bk

Aug 10, 2025 · 1 followers View post →
NEJM.org
@nejm.org · Bluesky

CONFIDENCE trial: In persons with chronic kidney disease and type 2 diabetes, combination therapy with finerenone and empagliflozin led to a greater reduction in the urinary albumin-to-creatinine ratio than either drug alone. Full trial results and Research Summary: nej.md/4jEVbbk

Aug 10, 2025 · 5 likes · 1 share View post →
Luis Goig
@Luisete68 · X

RT @SEMERGENap: Estudio CONFIDENCE (NEJM, 2025): en DM2 y ERC, la combinación finerenona + empagliflozina logró reducir un 29-32% la relaci…

Aug 10, 2025 · 3 shares · 28 followers View post →
SEMERGEN | Médicos de AP #SEMERGEN25
@SEMERGENap · X

Estudio CONFIDENCE (NEJM, 2025): en DM2 y ERC, la combinación finerenona + empagliflozina logró reducir un 29-32% la relación albúmina/creatinina vs monoterapia vía @SergioCinza

Aug 10, 2025 · 3 likes · 3 shares · 33,070 followers View post →
キャスバルレムダイクン@learning medicine student.
@in6b85t4 · X

RT @NEJM: Original Article: Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes (CONFIDENCE trial) https://t.co/Aqe…

Aug 10, 2025 · 54 shares · 46 followers View post →
VrBuatong
@VrBuatong · X

RT @NEJM: Original Article: Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes (CONFIDENCE trial) https://t.co/Aqe…

Aug 9, 2025 · 54 shares · 141 followers View post →
Fabricio Vassallo, MD, PhD
@fvassallomd · X

RT @NEJM: Original Article: Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes (CONFIDENCE trial) https://t.co/Aqe…

Aug 9, 2025 · 54 shares · 1,183 followers View post →
akho wey
@__peacebeyondme · X

RT @AAlMohammad87: #Finerenon_Empagliflozin & #RASi for #T2DM HbA1c<11 & #eGFR 30-90 & #urinary_ACR 100-5000 in #CONFIDENCE @NEJM lead to 2…

Aug 9, 2025 · 3 shares · 1,136 followers View post →
Prof Derek Connolly
@DrDerekConnolly · X

RT @NEJM: Original Article: Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes (CONFIDENCE trial) https://t.co/Aqe…

Aug 9, 2025 · 54 shares · 3,933 followers View post →
Jose Daniel Mosquera Lozano
@jdmosqueral · X

RT @NEJM: Original Article: Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes (CONFIDENCE trial) https://t.co/Aqe…

Aug 9, 2025 · 54 shares · 233 followers View post →
Nature's Medicines
@NatMed_Research · X

RT @NEJM: Original Article: Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes (CONFIDENCE trial) https://t.co/Aqe…

Aug 9, 2025 · 54 shares · 2,952 followers View post →
Zia Durrani
@ziakmcite · X

RT @NEJM: Original Article: Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes (CONFIDENCE trial) https://t.co/Aqe…

Aug 9, 2025 · 54 shares · 373 followers View post →
Dimitra Antonakaki
@DAntonakaki · X

RT @NEJM: Original Article: Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes (CONFIDENCE trial) https://t.co/Aqe…

Aug 9, 2025 · 54 shares · 404 followers View post →
Jan Verwerft
@VerwerftJan · X

RT @AAlMohammad87: #Finerenon_Empagliflozin & #RASi for #T2DM HbA1c<11 & #eGFR 30-90 & #urinary_ACR 100-5000 in #CONFIDENCE @NEJM lead to 2…

Aug 9, 2025 · 3 shares · 4,233 followers View post →
Ed Márquez
@dremarquezr · X

RT @NEJM: Original Article: Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes (CONFIDENCE trial) https://t.co/Aqe…

Aug 9, 2025 · 54 shares · 2,854 followers View post →
Mark Belkin
@MarkBelkinMD · X

RT @NEJM: Original Article: Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes (CONFIDENCE trial) https://t.co/Aqe…

Aug 9, 2025 · 54 shares · 2,451 followers View post →
Alex Kasiakogias
@AKasiakogias · X

RT @NEJM: Original Article: Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes (CONFIDENCE trial) https://t.co/Aqe…

Aug 9, 2025 · 54 shares · 513 followers View post →
Abdallah Al-Mohammad
@AAlMohammad87 · X

The mean eGFR of patients in the #CONFIDENCE trial @NEJM was 54.2 ml/min/1.73 m sq, median urinary #ACR was 579 and mean HbA1c was 7.3 #CardioTwitter @sheffielduni @SheffieldHosp @RCPEdin https://t.co/7PnsjkS9CG

Aug 9, 2025 · 1 like · 928 followers View post →
Dr. Michael Alexander
@MichaelAlexandp · X

RT @NEJM: Original Article: Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes (CONFIDENCE trial) https://t.co/Aqe…

Aug 9, 2025 · 54 shares · 854 followers View post →
Muthu Vaduganathan
@mvaduganathan · X

RT @NEJM: Original Article: Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes (CONFIDENCE trial) https://t.co/Aqe…

Aug 9, 2025 · 54 shares · 9,240 followers View post →
Muthu Vaduganathan
@mvaduganathan · X

RT @AAlMohammad87: #Finerenon_Empagliflozin & #RASi for #T2DM HbA1c<11 & #eGFR 30-90 & #urinary_ACR 100-5000 in #CONFIDENCE @NEJM lead to 2…

Aug 9, 2025 · 3 shares · 9,240 followers View post →
Abdallah Al-Mohammad
@AAlMohammad87 · X

#Finerenon_Empagliflozin & #RASi for #T2DM HbA1c<11 & #eGFR 30-90 & #urinary_ACR 100-5000 in #CONFIDENCE @NEJM lead to 29% or 32% reduction of #Urinary_ACR vs either agent alone, respectively #CardioTwitter @sheffielduni @mvaduganathan @BSHeartFailure https://t.co/7PnsjkS9CG

Aug 9, 2025 · 12 likes · 3 shares · 928 followers View post →
Gabriel Paredes, MD, FACC, FSSC
@gnparedes · X

RT @NEJM: Original Article: Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes (CONFIDENCE trial) https://t.co/Aqe…

Aug 9, 2025 · 54 shares · 363 followers View post →
Guy-Stone, MD, MPH
@MPH_Stone · X

RT @NEJM: Original Article: Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes (CONFIDENCE trial) https://t.co/Aqe…

Aug 9, 2025 · 54 shares · 583 followers View post →
Nada Hassib
@NadaHassib1 · X

RT @NEJM: Original Article: Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes (CONFIDENCE trial) https://t.co/Aqe…

Aug 9, 2025 · 54 shares · 768 followers View post →
Rajesh Samota
@dr_samota11 · X

RT @NEJM: Original Article: Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes (CONFIDENCE trial) https://t.co/Aqe…

Aug 9, 2025 · 54 shares · 311 followers View post →
Truthoverdishonesty
@Nigelj08223326 · X

Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes https://t.co/KUU7kNlMpu chronic kidney disease + NIDDM2 finerenone plus empagliflozin led to a greater reduction in the urinary albumin-to-creatinine ratio than either treatment alone @AskDrShashank https://t.co/irq7b7Wdov

Aug 9, 2025 · 1,607 followers View post →
Carlos Palacio
@CAPE1223 · X

RT @NEJM: Original Article: Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes (CONFIDENCE trial) https://t.co/Aqe…

Aug 9, 2025 · 54 shares · 1,030 followers View post →
Liam Brown
@liambrownmn · X

RT @NEJM: Original Article: Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes (CONFIDENCE trial) https://t.co/Aqe…

Aug 9, 2025 · 54 shares · 30 followers View post →
Gerhard Krämer
@MEcfsGerhard · X

RT @NEJM: Original Article: Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes (CONFIDENCE trial) https://t.co/Aqe…

Aug 9, 2025 · 54 shares · 22 followers View post →
Omar MedtechExpert
@Chess_MasterOK · X

RT @NEJM: Original Article: Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes (CONFIDENCE trial) https://t.co/Aqe…

Aug 9, 2025 · 54 shares · 13 followers View post →
Reza Ghanavati, MD.
@Ghanavati_r · X

#CardioEBM #CardioED #MedX #CVBoardPearl #Cardiotwitter In CKD and type 2 diabetes, finerenone plus empagliflozin reduces urinary albumin-to-creatinine ratio more than either alone. https://t.co/WhKIrQOvGC https://t.co/3A0IEPbX2R

Aug 9, 2025 · 326 followers View post →
Dr Richard Hirschson
@richardhirschs1 · X

https://t.co/UvH3S5rJfI

Aug 9, 2025 · 2 likes · 14,143 followers View post →
Neo_ID เป็นพ่อมดสัตว์จิ๋ว
@1IDCNMI · X

RT @NEJM: Original Article: Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes (CONFIDENCE trial) https://t.co/Aqe…

Aug 9, 2025 · 54 shares · 29,147 followers View post →
Pannawat Patra
@PannawatPa36600 · X

RT @NEJM: Original Article: Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes (CONFIDENCE trial) https://t.co/Aqe…

Aug 8, 2025 · 54 shares · 5 followers View post →
Alicia Yepez
@YepezDra · X

RT @NEJM: Original Article: Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes (CONFIDENCE trial) https://t.co/Aqe…

Aug 8, 2025 · 54 shares · 3,122 followers View post →
kelvin Orare
@kelvinOrare · X

RT @NEJM: Original Article: Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes (CONFIDENCE trial) https://t.co/Aqe…

Aug 8, 2025 · 54 shares · 561 followers View post →
INTERNAL MEDICINE
@medicinterna · X

RT @NEJM: Original Article: Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes (CONFIDENCE trial) https://t.co/Aqe…

Aug 8, 2025 · 54 shares · 2,463 followers View post →
Dr Ashish Kumar
@DrAshish_Kumar · X

RT @NEJM: Original Article: Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes (CONFIDENCE trial) https://t.co/Aqe…

Aug 8, 2025 · 54 shares · 19,338 followers View post →
キャスバルレムダイクン@learning medicine student.
@in6b85t4 · X

RT @NEJM: Original Article: Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes (CONFIDENCE trial) https://t.co/Aqe…

Aug 8, 2025 · 54 shares · 46 followers View post →
Tobias B. Huber
@Tobias_B_Huber · X

RT @NEJM: Original Article: Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes (CONFIDENCE trial) https://t.co/Aqe…

Aug 8, 2025 · 54 shares · 1,499 followers View post →
青島周一@【書籍】「生成AIと学ぶ医学論文の読み方・考え方」発売中！
@syuichiao89 · X

RT @NEJM: Original Article: Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes (CONFIDENCE trial) https://t.co/Aqe…

Aug 8, 2025 · 54 shares · 8,604 followers View post →
Jose Hernandez
@Pharma_Mty · X

RT @NEJM: Original Article: Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes (CONFIDENCE trial) https://t.co/Aqe…

Aug 8, 2025 · 54 shares · 195 followers View post →
Massimo Romano
@dottmasroman · X

RT @NEJM: Original Article: Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes (CONFIDENCE trial) https://t.co/Aqe…

Aug 8, 2025 · 54 shares · 356 followers View post →
andres
@palacioendocrin · X

RT @NEJM: Original Article: Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes (CONFIDENCE trial) https://t.co/Aqe…

Aug 8, 2025 · 54 shares · 356 followers View post →
Dr. Fernando
@rotavirus1980 · X

Finerenona con empagliflozina en la enfermedad renal crónica y la diabetes tipo 2 | Revista de Medicina de Nueva Inglaterra https://t.co/D7BZFQkVfZ

Aug 8, 2025 · 187 followers View post →
yara eid
@yaraabukalam · X

RT @NEJM: Original Article: Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes (CONFIDENCE trial) https://t.co/Aqe…

Aug 8, 2025 · 54 shares · 70 followers View post →
Cristina de la Mata
@Crisirenedlm · X

RT @NEJM: Original Article: Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes (CONFIDENCE trial) https://t.co/Aqe…

Aug 8, 2025 · 54 shares · 285 followers View post →
졸업 마려운 LR0725
@lr0725 · X

RT @NEJM: Original Article: Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes (CONFIDENCE trial) https://t.co/Aqe…

Aug 8, 2025 · 54 shares · 166 followers View post →
Heriberto Cabrales
@Hcabdajil · X

RT @NEJM: Original Article: Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes (CONFIDENCE trial) https://t.co/Aqe…

Aug 8, 2025 · 54 shares · 406 followers View post →
Otoo Kwesi Amonoo
@nattyoo8 · X

RT @NEJM: Original Article: Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes (CONFIDENCE trial) https://t.co/Aqe…

Aug 8, 2025 · 54 shares · 1,445 followers View post →
Sintayehu Abebe
@sinta_gf · X

RT @NEJM: Original Article: Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes (CONFIDENCE trial) https://t.co/Aqe…

Aug 8, 2025 · 54 shares · 452 followers View post →
Niyi
@NiyiMk · X

RT @NEJM: Original Article: Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes (CONFIDENCE trial) https://t.co/Aqe…

Aug 8, 2025 · 54 shares · 1,867 followers View post →
Henry Quinones
@HenryQuinones1 · X

RT @NEJM: Original Article: Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes (CONFIDENCE trial) https://t.co/Aqe…

Aug 8, 2025 · 54 shares · 256 followers View post →
Zaheer Bayat
@ZaheerBayat786 · X

RT @NEJM: Original Article: Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes (CONFIDENCE trial) https://t.co/Aqe…

Aug 8, 2025 · 54 shares · 283 followers View post →
NEJM
@NEJM · X

Original Article: Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes (CONFIDENCE trial) https://t.co/AqeFwQNqpn Editorial: Combination Therapy for Chronic Kidney Disease and Type 2 Diabetes — A Promising Prelude https://t.co/83I3getbLw #Endocrinology https://t.co/gUuxxgSLiH

Aug 8, 2025 · 144 likes · 54 shares · 935,950 followers View post →
Dr. Davinski
@neuro_davinski · X

RT @NEJM: New in the August 7, 2025, issue of NEJM: Finerenone with Empagliflozin in CKD and Diabetes (CONFIDENCE trial) https://t.co/Aq…

Aug 8, 2025 · 25 shares · 490 followers View post →
Roberto Gutiérrez
@DrRobertoGuti · X

RT @crz_garrit: Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes | New England Journal of Medicine https://t.co/…

Aug 8, 2025 · 4 shares · 784 followers View post →
S.E.N. Nefrología
@SENefrologia · X

RT @crz_garrit: Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes | New England Journal of Medicine https://t.co/…

Aug 8, 2025 · 4 shares · 21,924 followers View post →
Marko
@Markotelomerase · X

RT @NEJM: New in the August 7, 2025, issue of NEJM: Finerenone with Empagliflozin in CKD and Diabetes (CONFIDENCE trial) https://t.co/Aq…

Aug 8, 2025 · 25 shares · 65 followers View post →
CardioAcademic
@CardioAcademic · X

RT @NEJM: New in the August 7, 2025, issue of NEJM: Finerenone with Empagliflozin in CKD and Diabetes (CONFIDENCE trial) https://t.co/Aq…

Aug 8, 2025 · 25 shares · 3,223 followers View post →
SEMERGEN | Médicos de AP #SEMERGEN25
@SEMERGENap · X

RT @NEJM: New in the August 7, 2025, issue of NEJM: Finerenone with Empagliflozin in CKD and Diabetes (CONFIDENCE trial) https://t.co/Aq…

Aug 7, 2025 · 25 shares · 33,070 followers View post →
N
@NCKAR1999 · X

RT @NEJM: New in the August 7, 2025, issue of NEJM: Finerenone with Empagliflozin in CKD and Diabetes (CONFIDENCE trial) https://t.co/Aq…

Aug 7, 2025 · 25 shares · 14 followers View post →
Dr. Ronald Caraballo NEFROLOGO
@ronald_nefro · X

RT @NEJM: New in the August 7, 2025, issue of NEJM: Finerenone with Empagliflozin in CKD and Diabetes (CONFIDENCE trial) https://t.co/Aq…

Aug 7, 2025 · 25 shares · 662 followers View post →
Daniel Pita, MD
@danpita · X

RT @NEJM: New in the August 7, 2025, issue of NEJM: Finerenone with Empagliflozin in CKD and Diabetes (CONFIDENCE trial) https://t.co/Aq…

Aug 7, 2025 · 25 shares · 1,305 followers View post →
SultanSBAlSA
@SultanSBAlSA · X

RT @NEJM: New in the August 7, 2025, issue of NEJM: Finerenone with Empagliflozin in CKD and Diabetes (CONFIDENCE trial) https://t.co/Aq…

Aug 7, 2025 · 25 shares · 46 followers View post →
Manuel Vazquez V
@ManuelVVidaurre · X

RT @NEJM: New in the August 7, 2025, issue of NEJM: Finerenone with Empagliflozin in CKD and Diabetes (CONFIDENCE trial) https://t.co/Aq…

Aug 7, 2025 · 25 shares · 278 followers View post →
Giuseppe Galati
@GiuseppeGalati_ · X

RT @NEJM: New in the August 7, 2025, issue of NEJM: Finerenone with Empagliflozin in CKD and Diabetes (CONFIDENCE trial) https://t.co/Aq…

Aug 7, 2025 · 25 shares · 10,470 followers View post →
AperturaFarmaciasv
@danielsaravias1 · X

RT @BITNavarra: (NEJM) Tratamiento con finerenona y empagliflozina en pacientes con ERC y DM tipo II.

Aug 7, 2025 · 4 shares · 23 followers View post →
Massimo Romano
@dottmasroman · X

RT @NEJM: New in the August 7, 2025, issue of NEJM: Finerenone with Empagliflozin in CKD and Diabetes (CONFIDENCE trial) https://t.co/Aq…

Aug 7, 2025 · 25 shares · 356 followers View post →
Sergio Ríos Sibaja
@SergioRosSibaj1 · X

RT @NEJM: New in the August 7, 2025, issue of NEJM: Finerenone with Empagliflozin in CKD and Diabetes (CONFIDENCE trial) https://t.co/Aq…

Aug 7, 2025 · 25 shares · 30 followers View post →
Habib Cissé
@Kissiland_man · X

RT @NEJM: New in the August 7, 2025, issue of NEJM: Finerenone with Empagliflozin in CKD and Diabetes (CONFIDENCE trial) https://t.co/Aq…

Aug 7, 2025 · 25 shares · 893 followers View post →
FLBeachMom
@teriparsons101 · X

RT @NEJM: New in the August 7, 2025, issue of NEJM: Finerenone with Empagliflozin in CKD and Diabetes (CONFIDENCE trial) https://t.co/Aq…

Aug 7, 2025 · 25 shares · 309 followers View post →
Sudhir Kumar
@sudhirkirar1 · X

RT @NEJM: New in the August 7, 2025, issue of NEJM: Finerenone with Empagliflozin in CKD and Diabetes (CONFIDENCE trial) https://t.co/Aq…

Aug 7, 2025 · 25 shares · 321 followers View post →
Manuel Méndez
@mendez_bailon · X

RT @NEJM: New in the August 7, 2025, issue of NEJM: Finerenone with Empagliflozin in CKD and Diabetes (CONFIDENCE trial) https://t.co/Aq…

Aug 7, 2025 · 25 shares · 7,782 followers View post →
andres
@palacioendocrin · X

Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes | New England Journal of Medicine https://t.co/rpJwaBUd0C

Aug 7, 2025 · 356 followers View post →
L.
@nevverv · X

RT @BITNavarra: (NEJM) Tratamiento con finerenona y empagliflozina en pacientes con ERC y DM tipo II.

Aug 7, 2025 · 4 shares · 380 followers View post →
Josep Maria Cruzado
@crz_garrit · X

Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes | New England Journal of Medicine https://t.co/EdQhS4dBdq

Aug 7, 2025 · 8 likes · 4 shares · 1,019 followers View post →
Marwa Saleh
@EpiCuisineFan · X

RT @NEJM: New in the August 7, 2025, issue of NEJM: Finerenone with Empagliflozin in CKD and Diabetes (CONFIDENCE trial) https://t.co/Aq…

Aug 7, 2025 · 25 shares · 6 followers View post →
John P Erwin III MD MBA MACC (#BigPoppy )
@HeartOTXHeartMD · X

RT @NEJM: New in the August 7, 2025, issue of NEJM: Finerenone with Empagliflozin in CKD and Diabetes (CONFIDENCE trial) https://t.co/Aq…

Aug 7, 2025 · 25 shares · 39,674 followers View post →
Lucsob
@sobcuer · X

RT @NEJM: New in the August 7, 2025, issue of NEJM: Finerenone with Empagliflozin in CKD and Diabetes (CONFIDENCE trial) https://t.co/Aq…

Aug 7, 2025 · 25 shares · 256 followers View post →
Cristobal Morales
@CristobMorales · X

RT @NEJM: New in the August 7, 2025, issue of NEJM: Finerenone with Empagliflozin in CKD and Diabetes (CONFIDENCE trial) https://t.co/Aq…

Aug 7, 2025 · 25 shares · 17,074 followers View post →
Docencia MFYC BAires
@MfycBaires · X

RT @jamunozg62: Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes | New England Journal of Medicine https://t.co/…

Aug 7, 2025 · 1 share · 83 followers View post →
Ali Shah
@da474315 · X

RT @NEJM: New in the August 7, 2025, issue of NEJM: Finerenone with Empagliflozin in CKD and Diabetes (CONFIDENCE trial) https://t.co/Aq…

Aug 7, 2025 · 25 shares · 4,018 followers View post →
Muthu Vaduganathan
@mvaduganathan · X

RT @NEJM: New in the August 7, 2025, issue of NEJM: Finerenone with Empagliflozin in CKD and Diabetes (CONFIDENCE trial) https://t.co/Aq…

Aug 7, 2025 · 25 shares · 9,240 followers View post →
Ashok
@dr_ashok0124 · X

RT @NEJM: New in the August 7, 2025, issue of NEJM: Finerenone with Empagliflozin in CKD and Diabetes (CONFIDENCE trial) https://t.co/Aq…

Aug 7, 2025 · 25 shares · 269 followers View post →
NEJM
@NEJM · X

New in the August 7, 2025, issue of NEJM: Finerenone with Empagliflozin in CKD and Diabetes (CONFIDENCE trial) https://t.co/AqeFwQNqpn Ciprofloxacin Monotherapy for Bubonic Plague (IMASOY trial) https://t.co/N42b8KPRxE Vepdegestrant in Advanced Breast Cancer (VERITAC-2 https://t.co/1A7jzMFxN6

Aug 7, 2025 · 100 likes · 25 shares · 935,950 followers View post →
Alberto Pérez Dguez
@AlbertoPrezDgue · X

RT @BITNavarra: (NEJM) Tratamiento con finerenona y empagliflozina en pacientes con ERC y DM tipo II.

Aug 7, 2025 · 4 shares · 62 followers View post →
emiliamontagud
@emiliamontagud · X

RT @BITNavarra: (NEJM) Tratamiento con finerenona y empagliflozina en pacientes con ERC y DM tipo II.

Aug 7, 2025 · 4 shares · 89 followers View post →
BaladoCritique : club de lecture médical
@baladocritique.bsky.social · Bluesky

"Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes." Publié ce jour dans le @nejm.org #MedSky www.nejm.org/doi/full/10....

Aug 7, 2025 View post →
BIT Navarra
@BITNavarra · X

(NEJM) Tratamiento con finerenona y empagliflozina en pacientes con ERC y DM tipo II.

Aug 7, 2025 · 6 likes · 4 shares · 6,012 followers View post →
Javier Muñoz Gutiérz
@jamunozg62 · X

Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes | New England Journal of Medicine https://t.co/qcTU5bQA1I

Aug 7, 2025 · 1 share · 330 followers View post →
Docencia MFYC BAires
@MfycBaires · X

Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes | New England Journal of Medicine https://t.co/N0ctU41E7Z

Aug 7, 2025 · 83 followers View post →
Quertzalberin
@quertzalberin · X

https://t.co/Vb2dM7mGar

Aug 6, 2025 · 1 like · 310 followers View post →
Joyce Bwombengi
@kemuntoMD · X

RT @namesh217:

Aug 1, 2025 · 12 shares · 1,084 followers View post →
診療看護師（NP）【仮】
@marinp2025 · X

慢性腎臓病+糖尿病へのフィネレノン CONFIDENCE研究 ベースでRAS内服 主要評価項目: 尿中alb/Crの相対変化量 3群: finerenone，empagliflozin，fine and empa それぞれの単独療法との比較では，併用すると約30%程度主要評価項目が改善した https://t.co/QTHnhmZhia

Jul 18, 2025 · 51 followers View post →
Dr. Milton Milton Montaño H. Cardiólogo
@Genio20cardio · X

RT @JaimeMazonRuiz: Simultaneous initiation of finerenone + SGLT2i provides early and additive effects on UACR reduction, statistically and…

Jul 17, 2025 · 24 shares · 1,077 followers View post →
Nephrology Journal Club
@NephJC · X

2/10 What did I miss? There has been evidence pointing towards an additive effect of the combination with SGLT2i + MRAs, seen in ROTATE3 and FIDELITY. CONFIDENCE tried to answer the question: how safe and effective is it really? https://t.co/m81fkIFSA6 https://t.co/rrXjCRPl6r

Jul 16, 2025 · 8 likes · 38,319 followers View post →
Nephrology Journal Club
@nephjc.bsky.social · Bluesky

2/10 What did I miss? There has been evidence pointing towards an additive effect of the combination with SGLT2i + MRAs, seen in ROTATE3 and FIDELITY. CONFIDENCE tried to answer the question: how safe and effective is it really? pubmed.ncbi.nlm.nih.gov/40470996/

Jul 16, 2025 · 2 likes · 1 share View post →
Muthu Vaduganathan
@mvaduganathan · X

RT @JaimeMazonRuiz: Simultaneous initiation of finerenone + SGLT2i provides early and additive effects on UACR reduction, statistically and…

Jul 16, 2025 · 24 shares · 9,240 followers View post →
Maria Jose Soler
@PepaSolerR · X

RT @JaimeMazonRuiz: Simultaneous initiation of finerenone + SGLT2i provides early and additive effects on UACR reduction, statistically and…

Jul 16, 2025 · 24 shares · 4,722 followers View post →
Abraham Fatah, MD
@fatahabraham · X

RT @mvaduganathan:

Jul 16, 2025 · 98 shares · 37 followers View post →
Mjose Espigares
@MjoseEspigares · X

RT @JaimeMazonRuiz: Simultaneous initiation of finerenone + SGLT2i provides early and additive effects on UACR reduction, statistically and…

Jul 15, 2025 · 24 shares · 475 followers View post →
MdCardio
@MdCardio_1981 · X

Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes https://t.co/2IRTaXyGUX

Jul 8, 2025 · 10 followers View post →
Husnain Mehboob
@Hussnainme · X

RT @namesh217:

Jul 8, 2025 · 12 shares · 169 followers View post →
Leonard LN
@leonard49411022 · X

RT @AmbrizMau: En enfermedad renal crónica con diabetes tipo 2, combinación inicial de finerenona y empagliflozina redujo más la razón albú…

Jul 8, 2025 · 4 shares · 238 followers View post →
Tom Hsiung
@TomHsiung · X

Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes | New England Journal of Medicine https://t.co/bg1VyBfsc4

Jul 8, 2025 · 1 like · 464 followers View post →
Josegabortega4
@josegabortega4 · X

RT @NEJM: Original Article: Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes (CONFIDENCE trial) https://t.co/Aqe…

Jul 7, 2025 · 59 shares · 16 followers View post →
Dr Theepa N.M.R
@TNesam · X

RT @namesh217:

Jul 7, 2025 · 12 shares · 697 followers View post →
Almansour
@malmansour81 · X

RT @namesh217:

Jul 7, 2025 · 12 shares · 214 followers View post →
Gopambuj Singh Rathod
@IamGopambuj · X

RT @namesh217:

Jul 7, 2025 · 12 shares · 2,959 followers View post →
X_MEDICINE_X
@XMedicinedoc · X

RT @namesh217:

Jul 7, 2025 · 12 shares · 81 followers View post →
Pulkit khosla
@Pulkitkhosla17 · X

RT @namesh217:

Jul 7, 2025 · 12 shares · 8 followers View post →
Dr. Hardik Patel
@hardik4u24 · X

RT @namesh217:

Jul 7, 2025 · 12 shares · 3,004 followers View post →
Namesh kamat
@namesh217 · X

Jul 7, 2025 · 39 likes · 12 shares · 245 followers View post →
DiegoGonzlezGu1
@DiegoGonzlezGu1 · X

Jul 6, 2025 · 1 share · 447 followers View post →
Dr.NefroBoy
@iAlanagc · X

RT @NefroClassMx: CONFIDENCE En DM2 + ERC finerenona + empagliflozina ↓ albuminuria 52% a 180 días. ➕29% vs finerenona ➕32% vs empaglifloz…

Jul 6, 2025 · 36 shares · 71 followers View post →
Cristina Popa
@NephroSeeker · X

RT @NephJC: Neph Journal Club I'm gonna keep on writing at the Neph Journal Club I'm gonna keep on hosting down on the #Bluesky App I'm gon…

Jul 4, 2025 · 2 shares · 2,979 followers View post →
Natalia Nombera Aznaran
@roxnonna23 · X

RT @NephJC: Neph Journal Club I'm gonna keep on writing at the Neph Journal Club I'm gonna keep on hosting down on the #Bluesky App I'm gon…

Jul 3, 2025 · 2 shares · 181 followers View post →
東北大学 循環器内科
@cardio_tu · X

2 min cardiology（臨床、担当：後岡広太郎） Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes Rajiv Agarwal et al. NEJM June 5, 2025. https://t.co/Nv37IjKq2n →

Jul 3, 2025 · 3 likes · 1,321 followers View post →
andres
@palacioendocrin · X

Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes | New England Journal of Medicine https://t.co/5iaqLE9mtF

Jul 1, 2025 · 356 followers View post →
Dr Celestino Gutiérrez González MD
@CelestinoGutirr · X

RT @drbennisahmed: Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes At day 180, the reduction in the urinary al…

Jul 1, 2025 · 7 shares · 11,309 followers View post →
Dr. Ronald Caraballo NEFROLOGO
@ronald_nefro · X

RT @drbennisahmed: Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes At day 180, the reduction in the urinary al…

Jun 30, 2025 · 7 shares · 662 followers View post →
Mohammad Aleidi
@aleidimed · X

RT @drbennisahmed: Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes At day 180, the reduction in the urinary al…

Jun 30, 2025 · 7 shares · 311 followers View post →
FreeGene
@Freedom30167 · X

RT @drbennisahmed: Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes At day 180, the reduction in the urinary al…

Jun 30, 2025 · 7 shares · 32 followers View post →
mocchi
@mocchi_ym · X

RT @drbennisahmed: Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes At day 180, the reduction in the urinary al…

Jun 30, 2025 · 7 shares · 214 followers View post →
Alfredo Velázquez Mtez.
@DRvelazquezA · X

RT @drbennisahmed: Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes At day 180, the reduction in the urinary al…

Jun 30, 2025 · 7 shares · 225 followers View post →
ALKINDY Abdulrhman
@Abdul_alkindy · X

RT @drbennisahmed: Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes At day 180, the reduction in the urinary al…

Jun 30, 2025 · 7 shares · 829 followers View post →
Ahmed Bennis MD
@drbennisahmed · X

Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes At day 180, the reduction in the urinary albumin-to-creatinine ratio with combination therapy was 29% greater than that with finerenone alone and 32% greater than that with empagliflozin alone Among https://t.co/wUI6aZNp09

Jun 30, 2025 · 19 likes · 7 shares · 2,764 followers View post →
shabmeir شبمیر
@shabmier · X

Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes | New England Journal of Medicine https://t.co/dB3542U0jI

Jun 30, 2025 · 507 followers View post →
NephroLOGY BOX. GUO's
@ulusalokyay · X

RT @drbennisahmed: Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes initial therapy with finerenone plus empagl…

Jun 29, 2025 · 8 shares · 170 followers View post →
imquang
@imquang · X

Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes | New England Journal of Medicine https://t.co/ehvo3SomiN

Jun 26, 2025 · 79 followers View post →
Hakan Demirtürk
@HakanDemirturk · X

RT @JasmineNephro:

Jun 24, 2025 · 29 shares · 138 followers View post →
Clinical cardiology
@Mahmoud33986639 · X

RT @ValleAlfonso: Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes

Jun 24, 2025 · 35 shares · 251 followers View post →
Mar
@marianaaggvv · X

RT @drbennisahmed: Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes initial therapy with finerenone plus empagl…

Jun 21, 2025 · 8 shares · 107 followers View post →
@MARTINSVEL
@MARTINSVEL · X

RT @drbennisahmed: Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes initial therapy with finerenone plus empagl…

Jun 20, 2025 · 8 shares · 413 followers View post →
®@』ǜ
@AWAISSH13 · X

RT @drbennisahmed: Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes initial therapy with finerenone plus empagl…

Jun 20, 2025 · 8 shares · 69 followers View post →
Muthu Vaduganathan
@mvaduganathan · X

RT @drbennisahmed: Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes initial therapy with finerenone plus empagl…

Jun 20, 2025 · 8 shares · 9,240 followers View post →
ALKINDY Abdulrhman
@Abdul_alkindy · X

RT @drbennisahmed: Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes initial therapy with finerenone plus empagl…

Jun 20, 2025 · 8 shares · 829 followers View post →
Blessing Muponda
@BMuponda · X

RT @drbennisahmed: Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes initial therapy with finerenone plus empagl…

Jun 20, 2025 · 8 shares · 100 followers View post →
Ahmed Bennis MD
@drbennisahmed · X

Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes initial therapy with finerenone plus empagliflozin led to a greater reduction in the urinary albumin-to-creatinine ratio than either treatment alone https://t.co/wpQWmMUCV5 https://t.co/vpmimxGRzq

Jun 20, 2025 · 22 likes · 8 shares · 2,764 followers View post →
Tskkm0117
@Tskkm0117 · X

Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes | New England Journal of Medicine https://t.co/K4Bdv2avFw

Jun 15, 2025 · 1 followers View post →
STITCHES Medicine - the Best of Medical Research
@medicine.stitches.today · Bluesky

Combining finerenone with empagliflozin significantly reduces kidney damage in patients with chronic kidney disease and type 2 diabetes. by Agarwal R, Green JB (...) Nangaku M et 12 al. in N Engl J Med #MedSky

Jun 14, 2025 · 9 likes · 1 share View post →
STITCHES Medicine - the Best of Medical Research
@STITCHESMed · X

Combining finerenone with empagliflozin significantly reduces kidney damage in patients with chronic kidney disease and type 2 diabetes. by Agarwal R, Green JB (...) Nangaku M et 12 al. in N Engl J Med https://t.co/OOxNHaR3ES #MedX #MedResearch

Jun 14, 2025 · 87 followers View post →
digoxin
@7iraeth · X

Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes | New England Journal of Medicine https://t.co/EZp6zDPYUh

Jun 14, 2025 · 86 followers View post →
Research Bites
@Research_Bites · X

A new study shows that combining finerenone with empagliflozin significantly reduces protein in urine for people with chronic kidney disease and type 2 diabetes, outperforming either drug alone without increasing safety risks. - Read more: https://t.co/OR65fdqKuN

Jun 13, 2025 · 3 likes · 1,069 followers View post →
Andres Felipe Florez
@Andresffmed · X

RT @NEJM: Original Article: Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes (CONFIDENCE trial) https://t.co/Aqe…

Jun 12, 2025 · 59 shares · 158 followers View post →
Research Bites
@Research_Bites · X

A recent study found that combining finerenone and empagliflozin significantly reduces protein in urine more than either drug alone in people with chronic kidney disease and type 2 diabetes, without major safety concerns. - Read more: https://t.co/OR65fdqKuN

Jun 12, 2025 · 1 like · 1,069 followers View post →
Research Bites
@Research_Bites · X

A study found that combining finerenone with empagliflozin reduced harmful urinary proteins more effectively than either drug alone in patients with chronic kidney disease and type 2 diabetes, without increasing side effects. - Read more: https://t.co/OR65fdqKuN

Jun 12, 2025 · 5 likes · 1,069 followers View post →
Life Science Journal Content
@lsn_jc · X

Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes #science #publication #research #journal https://t.co/AnwAwFWsm4

Jun 12, 2025 · 1 like · 261 followers View post →
Kathrine Parker
@KattyParker84 · X

RT @NEJM: Original Article: Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes (CONFIDENCE trial) https://t.co/Aqe…

Jun 12, 2025 · 59 shares · 237 followers View post →
Diana Isaacs, PharmD, BC-ADM, CDCES
@DianaMIsaacs · X

RT @RodolfoJGalindo: Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes ⁦@NEJM⁩ Excellent option for #CKD and #T…

Jun 8, 2025 · 4 shares · 3,140 followers View post →
Nep
@HadiMD_ · X

RT @JasmineNephro:

Jun 8, 2025 · 29 shares · 351 followers View post →
旅人 tabito
@tabibito250 · X

Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes | New England Journal of Medicine https://t.co/Y3wRSPUWzo

Jun 8, 2025 · 1,068 followers View post →
Research Bites
@Research_Bites · X

A new study shows that combining finerenone and empagliflozin in patients with chronic kidney disease and type 2 diabetes reduces urine albumin levels more effectively than either drug alone, without unexpected side effects. - Read more: https://t.co/OR65fdqKuN

Jun 8, 2025 · 2 likes · 1,069 followers View post →
Rahul khandelwal
@dr29rahul · X

RT @JasmineNephro:

Jun 8, 2025 · 29 shares · 2 followers View post →
pinacol
@pinacol · X

【RCT】アルブミン尿（100≤UACR≤5000）および2型糖尿病を伴うCKD（eGFR30-90mL/min/1.73m^2）患者へのフィネレノン+エンパグリフロジンは、フィネレノン単剤やエンパグリフロジン単剤と比較して、UACRを改善させた。 #ペ読 https://t.co/Le9eKEeL5j

Jun 8, 2025 · 2 likes · 1,616 followers View post →
mocchi
@mocchi_ym · X

RT @RodolfoJGalindo: Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes ⁦@NEJM⁩ Excellent option for #CKD and #T…

Jun 8, 2025 · 4 shares · 214 followers View post →
Abhishek
@aksrulz13 · X

RT @RodolfoJGalindo: Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes ⁦@NEJM⁩ Excellent option for #CKD and #T…

Jun 8, 2025 · 4 shares · 623 followers View post →
Dr. Ronald Caraballo NEFROLOGO
@ronald_nefro · X

RT @JasmineNephro:

Jun 7, 2025 · 29 shares · 662 followers View post →
Rodolfo J. Galindo MD
@RodolfoJGalindo · X

Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes ⁦@NEJM⁩ Excellent option for #CKD and #T2D https://t.co/OGF9NuzHKx

Jun 7, 2025 · 17 likes · 4 shares · 1,104 followers View post →
Research Bites
@Research_Bites · X

Jun 7, 2025 · 3 likes · 1,069 followers View post →
Tanjiro
@Tanjiro2401 · X

RT @JasmineNephro:

Jun 7, 2025 · 29 shares · 25 followers View post →
Julio César
@DrJulioMatuteM · X

RT @JasmineNephro:

Jun 7, 2025 · 29 shares · 1,422 followers View post →
kelvin Orare
@kelvinOrare · X

RT @JasmineNephro:

Jun 7, 2025 · 29 shares · 561 followers View post →
Dr Benil
@hafeeq_benil · X

RT @JasmineNephro:

Jun 7, 2025 · 29 shares · 392 followers View post →
Will
@_obiwill · X

RT @JasmineNephro:

Jun 7, 2025 · 29 shares · 732 followers View post →
Dr Jean Pierre Laroche #vacciné 6.0
@Echoraljpangio · X

RT @JasmineNephro:

Jun 7, 2025 · 29 shares · 2,713 followers View post →
Dr Jorge Ferradas Solar
@JorgeFerradasSo · X

RT @JasmineNephro:

Jun 7, 2025 · 29 shares · 1,270 followers View post →
Dr Celestino Gutiérrez González MD
@CelestinoGutirr · X

RT @JasmineNephro:

Jun 7, 2025 · 29 shares · 11,309 followers View post →
Dr. Jacob A. Thon
@JacoThon · X

RT @JasmineNephro:

Jun 7, 2025 · 29 shares · 2,456 followers View post →
Joyce Bwombengi
@kemuntoMD · X

RT @JasmineNephro:

Jun 7, 2025 · 29 shares · 1,084 followers View post →
Almansour
@malmansour81 · X

RT @JasmineNephro:

Jun 7, 2025 · 29 shares · 214 followers View post →
Nobody
@JasGill89421387 · X

RT @JasmineNephro:

Jun 7, 2025 · 29 shares · 94 followers View post →
Dr Kevin T John Keeppallil
@kevintjohn1 · X

RT @JasmineNephro:

Jun 7, 2025 · 29 shares · 1,597 followers View post →
Khushbinder dhiman
@Khushbinder11 · X

RT @JasmineNephro:

Jun 7, 2025 · 29 shares · 246 followers View post →
Vademon24292
@CarlosA09557330 · X

RT @JasmineNephro:

Jun 6, 2025 · 29 shares · 533 followers View post →
Israel Armida G
@ArmidaIsrael · X

RT @JasmineNephro:

Jun 6, 2025 · 29 shares · 388 followers View post →
diacavan
@diacavan · X

RT @JasmineNephro:

Jun 6, 2025 · 29 shares · 165 followers View post →
Mohammad Aleidi
@aleidimed · X

RT @JasmineNephro:

Jun 6, 2025 · 29 shares · 311 followers View post →
Rajiv Agarwal MD, MS
@AgarwalRajivMD · X

RT @JasmineNephro:

Jun 6, 2025 · 29 shares · 2,113 followers View post →
Frankie
@pacovelascor · X

RT @JasmineNephro:

Jun 6, 2025 · 29 shares · 171 followers View post →
Finerenona España
@KerendiaEsp · X

RT @JasmineNephro:

Jun 6, 2025 · 29 shares · 233 followers View post →
shahin mohammed
@shahsonride · X

RT @JasmineNephro:

Jun 6, 2025 · 29 shares · 498 followers View post →
Srinivas Mahesh Prasad Nephrologist
@NephPrasad · X

RT @JasmineNephro:

Jun 6, 2025 · 29 shares · 958 followers View post →
JorgeEdoChava75
@QicenoJorge · X

RT @JasmineNephro:

Jun 6, 2025 · 29 shares · 1,002 followers View post →
Jasmine Sethi
@JasmineNephro · X

Jun 6, 2025 · 93 likes · 29 shares · 25,811 followers View post →
Edgar V. Lerma
@edgarvlermamd.bsky.social · Bluesky

CONFIDENCE: Finerenone with Empagliflozin in CKD and T2D from @nejm.org #ERA25

Jun 6, 2025 · 7 likes · 3 shares View post →
EARLの医学&AIノート
@EARL_med_tw · X

Jun 6, 2025 · 7 likes · 148,046 followers View post →
Cravedi Lab
@cravedilab.bsky.social · Bluesky

Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes | New England Journal of Medicine www.nejm.org/doi/full/10....

Jun 5, 2025 · 1 like View post →